Published in Anticancer Res on May 18, 1993
Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med (1994) 2.14
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol (2012) 1.79
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol (2002) 1.74
Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int (1993) 1.56
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial. Cancer (1994) 1.55
Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Br J Rheumatol (1998) 1.54
Posterior fossa abnormalities in hereditary spastic paraparesis with spastin mutations. J Neurol Neurosurg Psychiatry (2009) 1.41
Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol (2002) 1.29
Kenny-Caffey syndrome in two sibs born to consanguineous parents: evidence for an autosomal recessive variant. Am J Med Genet (1992) 1.26
Prosthetic repair of a perforated Amyand's hernia: hazardous or feasible? Hernia (2007) 1.26
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Mapping of avirulence genes in Phytophthora infestans with amplified fragment length polymorphism markers selected by bulked segregant analysis. Genetics (2001) 1.16
The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant (2012) 1.15
Antigenic and molecular characterization of wild type 1 poliovirus causing outbreaks of poliomyelitis in Albania and neighboring countries in 1996. J Clin Microbiol (1998) 1.14
Epidemiology of Crohn's disease in Sicily: a hospital incidence study from 1987 to 1989. "The Sicilian Study Group of Inflammatory Bowel Disease". Eur J Epidemiol (1991) 1.10
On the possible causes of the release of material absorbing at 260 m-mu by streptomycin treated E. coli cells (K 12 and B). J Antibiot (Tokyo) (1967) 1.08
[Release of nucleotides and integrity of the bacterial membrane (E. coli K 12)]. Antibiotica (1966) 1.06
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. Ann Oncol (2005) 1.05
Efficacy of double intrauterine insemination in controlled ovarian hyperstimulation cycles. Fertil Steril (1999) 1.04
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers. Ann Oncol (2006) 1.03
Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci (2014) 1.02
Cathepsin D in the malignant progression of neoplastic diseases (review). Anticancer Res (1992) 1.01
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. J Clin Oncol (1988) 1.01
Surveillance of acute flaccid paralysis in Italy: 1996-1997. AFP Study Group. Acute flaccid paralysis. Eur J Epidemiol (1999) 1.00
Sporadic isolation of sabin-like polioviruses and high-level detection of non-polio enteroviruses during sewage surveillance in seven Italian cities, after several years of inactivated poliovirus vaccination. Appl Environ Microbiol (2014) 1.00
Realising the European Network of Biodosimetry (RENEB). Radiat Prot Dosimetry (2012) 0.99
EuCliD (European Clinical Database): a database comparing different realities. J Nephrol (2002) 0.99
Neuropsychological features of benign partial epilepsy in children. Ital J Neurol Sci (1990) 0.98
Permanent Genetic Resources added to Molecular Ecology Resources Database 1 April 2010 - 31 May 2010. Mol Ecol Resour (2010) 0.97
Thyroid carcinoma mimicking a toxic adenoma. Eur J Nucl Med (1990) 0.96
Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen) J Am Soc Nephrol (2000) 0.96
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features. Ann Oncol (2007) 0.95
Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade. Pharmacogenomics J (2004) 0.95
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients. Ann Oncol (2005) 0.95
Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses. Ultrasound Obstet Gynecol (2009) 0.95
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. J Cancer Res Clin Oncol (2002) 0.94
Cathepsin D, B and L circulating levels as prognostic markers of malignant progression. Anticancer Res (1996) 0.93
Serum antibodies to poliomyelitis in Italy. Bull World Health Organ (1984) 0.93
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer. Br J Cancer (2003) 0.93
Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects. Nephrol Dial Transplant (2001) 0.92
Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications. Oncology (1997) 0.92
Acute pain syndrome at tumour site in neoplastic patients treated with vinorelbine: report of unusual toxicity. Eur J Cancer (1994) 0.91
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1. Kidney Int (2000) 0.91
Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis. Cancer (1993) 0.91
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy. Anticancer Drugs (1993) 0.91
Anti-neutrophil cytoplasm antibodies in patients with monoclonal gammopathies. J Clin Lab Immunol (1990) 0.90
[Epidemiology of acute flaccid paralysis in Italy: 1996-98. Group for the Study of AFP]. Ann Ig (2000) 0.90
Single agent paclitaxel in advanced squamous cell head and neck carcinoma. Eur J Cancer (1996) 0.90
Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum Genet (1997) 0.90
Management of thyrotoxic crisis. Eur Rev Med Pharmacol Sci (2005) 0.90
Mortality in patients with Crohn's disease. Scand J Gastroenterol (1996) 0.89
Severe EBV hepatitis treated with valganciclovir. Infection (2012) 0.87
Cathepsin D serum mass concentrations in patients with hepatocellular carcinoma and/or liver cirrhosis. Eur J Clin Chem Clin Biochem (1996) 0.87
Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron (1990) 0.86
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. Nutr Metab Cardiovasc Dis (2011) 0.86
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma. Clin Cancer Res (2000) 0.86
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. Ann Oncol (2007) 0.86
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2. Cancer Immunol Immunother (1998) 0.86
EuCliD--a medical registry. Methods Inf Med (2004) 0.86
Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre. Clin Endocrinol (Oxf) (1997) 0.85
Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy. Eur J Clin Microbiol Infect Dis (2008) 0.85
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study. Oncol Rep (2010) 0.85
Chromosomal deletion in isolates of Phytophthora infestans correlates with virulence on R3, R10, and R11 potato lines. Mol Plant Microbe Interact (2001) 0.85
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study. Clin Ter (1999) 0.85
Person X situation interactionism in self-encoding (I am...when...): implications for affect regulation and social information processing. J Pers Soc Psychol (2001) 0.84
Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci (2003) 0.84
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int (1989) 0.84
[Adult congenital anomalies of the coronary arteries described over 31 years of angiographic studies in the Asturias Principality: main angiographic and clinical characteristics]. Rev Esp Cardiol (2001) 0.83
The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis. Am J Hypertens (2000) 0.83
Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis. Pancreas (1997) 0.83
Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness. Mod Pathol (1994) 0.83
Emotional expression and coping style in female breast cancer. Ann Oncol (2007) 0.83
Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases. Br J Cancer (1993) 0.83
The effects of the macrocyclic lactone bryostatin-1 on leukemic cells in vitro. Tumori (1992) 0.83
Traction on the retina induced by saccadic eye movements in the presence of posterior vitreous detachment. Biomech Model Mechanobiol (2010) 0.83
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma. J Chemother (1993) 0.83
Essential amino acid supplementation in patients with severe COPD: a step towards home rehabilitation. Monaldi Arch Chest Dis (2012) 0.83
Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer: a phase II study of the Southern Italy Oncology Group (GOIM). Anticancer Drugs (1997) 0.83
Elective surgery for gastrointestinal tumours in the elderly. Ann Oncol (1997) 0.82
[Hemostatic effectiveness of TachoSil® patches in radiofrequency assisted minor hepatic resection]. Minerva Chir (2010) 0.82